Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of 14 Differentially-Expressed Metabolism-Related Genes as Potential Targets of Gastric Cancer by Integrated Proteomics and Transcriptomics. | Front Cell Dev Biol | 2022 | 35265615 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Metabolism-Associated Subtypes of Renal Cell Carcinoma to Aid Clinical Therapy. | Oxid Med Cell Longev | 2022 | 35265267 | PubTator, text mining | PubMed |
| Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. | Front Pharmacol | 2022 | 35264950 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist. | Sci Rep | 2022 | 35256673 | PubTator, text mining | PubMed |
| In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size. | Sci Rep | 2022 | 35246549 | PubTator, text mining | PubMed |
| Association between dietary saturated fat with cardiovascular disease risk markers and body composition in healthy adults: findings from the cross-sectional BODYCON study. | Nutr Metab (Lond) | 2022 | 35241101 | PubTator, text mining | PubMed |
| Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. | Front Endocrinol (Lausanne) | 2022 | 35237237 | PubTator, text mining | PubMed |
| Novel Insights Into Sterol Uptake and Intracellular Cholesterol Trafficking During Eimeria bovis Macromeront Formation. | Front Cell Infect Microbiol | 2022 | 35223543 | PubTator, text mining | PubMed |
| Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway. | Front Pharmacol | 2022 | 35222024 | PubTator, text mining | PubMed |
| Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management. | EXCLI J | 2022 | 35221836 | PubTator, text mining | PubMed |
| The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA). | Int J Mol Sci | 2022 | 35216289 | PubTator, text mining | PubMed |
| Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications. | Int J Mol Sci | 2022 | 35216285 | PubTator, text mining | PubMed |
| Structural Assembly of Qβ Virion and Its Diverse Forms of Virus-like Particles. | Viruses | 2022 | 35215818 | PubTator, text mining | PubMed |
| Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. | Nutrients | 2022 | 35215499 | PubTator, text mining | PubMed |
| It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases. | Cancers (Basel) | 2022 | 35205690 | PubTator, text mining | PubMed |
| ACAT2 Is a Novel Negative Regulator of Pig Intramuscular Preadipocytes Differentiation. | Biomolecules | 2022 | 35204738 | PubTator, text mining | PubMed |
| Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension. | Biomedicines | 2022 | 35203550 | PubTator, text mining | PubMed |
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis. | Cells | 2022 | 35203369 | PubTator, text mining | PubMed |
| Novel treatments for congenital adrenal hyperplasia. | Rev Endocr Metab Disord | 2022 | 35199280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=38